Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.

Zhang Y, Liu L, Bao H, Xu K, Zhang H, Wang S, Chang S, Zhu D, Huang Z, Wang Z, Yang L, Zhang B, Tao J, Liang W, Chen J, Yang S, Wu X, Shao Y, Wang W, Zhu D

Open source

DOI
10.1186/s43556-026-00497-2
Published
2026 Aug 5
Container
Molecular biomedicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s43556-026-00497-2,
  title = {Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.},
  author = {Zhang Y and Liu L and Bao H and Xu K and Zhang H and Wang S and Chang S and Zhu D and Huang Z and Wang Z and Yang L and Zhang B and Tao J and Liang W and Chen J and Yang S and Wu X and Shao Y and Wang W and Zhu D},
  year = {2026},
  journal = {Molecular biomedicine},
  doi = {10.1186/s43556-026-00497-2},
  url = {https://doi.org/10.1186/s43556-026-00497-2}
}

RIS

TY  - JOUR
TI  - Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.
AU  - Zhang Y
AU  - Liu L
AU  - Bao H
AU  - Xu K
AU  - Zhang H
AU  - Wang S
AU  - Chang S
AU  - Zhu D
AU  - Huang Z
AU  - Wang Z
AU  - Yang L
AU  - Zhang B
AU  - Tao J
AU  - Liang W
AU  - Chen J
AU  - Yang S
AU  - Wu X
AU  - Shao Y
AU  - Wang W
AU  - Zhu D
PY  - 2026
JO  - Molecular biomedicine
DO  - 10.1186/s43556-026-00497-2
UR  - https://doi.org/10.1186/s43556-026-00497-2
ER  - 

APA

Y, Z., L, L., H, B., K, X., H, Z., S, W., S, C., D, Z., Z, H., Z, W., L, Y., B, Z., J, T., W, L., J, C., S, Y., X, W., Y, S., W, W., & D, Z. (2026). Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer.. Molecular biomedicine. https://doi.org/10.1186/s43556-026-00497-2

Source records